|
Volumn 2, Issue 3, 2000, Pages 283-302
|
Prospectives for pharmacotherapy of male erectile dysfunction
a a a a |
Author keywords
Apomorphine; Corpus cavernosum; Erectile dysfunction; Impotence; Penile erection; PGE; Viagra
|
Indexed keywords
APOMORPHINE;
CHLORPROMAZINE;
CLONIDINE;
CYCLIC AMP;
CYCLIC GMP;
DOMPERIDONE;
DOPAMINE RECEPTOR;
DOPAMINE RECEPTOR STIMULATING AGENT;
FLUOXETINE;
FORSKOLIN;
GLYCERYL TRINITRATE;
HALOPERIDOL;
MILRINONE;
MINOXIDIL;
OXYTOCIN;
OXYTOCIN RECEPTOR;
PAPAVERINE;
PHENTOLAMINE;
PRAZOSIN;
PRECLAMOL;
PROSTAGLANDIN E1;
QUINELORANE;
QUINPIROLE;
SEROTONIN ANTAGONIST;
SEROTONIN RECEPTOR;
SILDENAFIL;
TRAZODONE;
YOHIMBINE;
CLINICAL TRIAL;
CORPUS CAVERNOSUM;
DRUG DESIGN;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SCREENING;
ELECTROSTIMULATION THERAPY;
ENZYME SYNTHESIS;
ERECTILE DYSFUNCTION;
EXPERIMENTAL MODEL;
HUMAN;
HYPOTHALAMUS FUNCTION;
IMPOTENCE;
NONHUMAN;
PENIS ERECTION;
QUALITY OF LIFE;
RECEPTOR BLOCKING;
REVIEW;
SEXUAL FUNCTION;
|
EID: 0033917913
PISSN: 1464844X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (10)
|
References (182)
|